mike doustdar - Search News

News

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar

Reuters on MSN · 1d

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO, shares plunge

Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to revive sales and a share price hit by worries the maker of weight-loss drug Wegovy is falling behind in a race it started.

Medical Dialogues · 1h

Novo Nordisk Appoints Mike Doustdar as New CEO Amid Executive Reshuffle

Delhi: Global healthcare major Novo Nordisk has announced the appointment of Maziar Mike Doustdar as its new President and Chief Executive Officer, effective 7 August 2025. The move comes as part

The Wall Street Journal on MSN · 18h

Can Novo Nordisk’s New CEO Stop Rivals From Taking Over the Anti-Obesity Market?

Danish leader will face a challenging landscape among competitors

1don MSN

Wegovy maker Novo's profit warning triggers $70 billion share rout

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...

1don MSN

Novo Lifer Takes Job of Reviving Europe’s Weight-Loss Superstar

Maziar Mike Doustdar spent more than three decades quietly climbing the ranks of Novo Nordisk A/S, from office clerk through ...

1don MSN

Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance

Danish pharmaceutical giant Novo Nordisk on Tuesday named its new CEO and cut its full-year sales and profit guidance.

Pharma Industry Shaken: New Leadership and Tariff Challenges

Novo Nordisk's new CEO, Maziar Mike Doustdar, faces challenges in reviving waning sales and shares in the weight-loss drug ...

1d

Instant View: Reaction to new Novo Nordisk CEO, profit warning

Novo's problems are much deeper than just compunded Wegovy in the U.S. and extend to the international Wegovy franchise and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results